Pay in 4 interest-free payments of $6.17 Learn more
Ships within 48 hours · Estimated delivery Aug 28 - Sep 2
By avoiding the growth hormone receptor/IGF-1 pathway entirely, AOD-9604 eliminates the appetite-modulating effects that make growth hormone therapy challenging for weight management
Trava Health company background Trava Health launched in 2023 out of Houston, Texas
Any provider prescribing or recommending BPC-157 alongside an SNRI is operating outside the evidence base and assumes full clinical responsibility for outcome monitoring
We also offer many other health services including Pharmacy First, Flu Vaccination, Blood Pressure Testing, and Weight Loss Injections (Mounjaro)
US$ 27.71
US$ 25.24
US$ 21.71
US$ 23.23
US$ 23.88
US$ 25.65
